VRDN
NASDAQ · Biotechnology
Viridian Therapeutics Inc
$16.61
-0.39 (-2.29%)
Analyst Consensus
Strong Buy
25
Analysts
High
Coverage
Price Target
Analyst Price Target
+284.3% upside
Low Target
$43.31
Average Target
$63.84
High Target
$68.31
Current Price
$16.61
Current
$16.61
$16.61
Target
$63.84
$63.84
$43.31
$63.84 avg
$68.31
Scenario Analysis
Bear Case
$43.31
160.7%
Low target
Base Case
$63.84
+284.3%
Avg target
Bull Case
$68.31
+311.3%
High target
Risk/Reward
1.9x
Balanced
Price in Context
52-Week High
$34.29
-51.6% from high
52-Week Low
$11.76
+41.2% from low
50-Day SMA
$31.51
-47.3% vs SMA
200-Day SMA
$22.43
-25.9% vs SMA
RSI (14)
17.6
Oversold
Target vs 52W High
$63.84
+86.2% vs high
Next Earnings Report
May 12, 2026
1d
tomorrow
EPS Est: $-1.12
Earnings in 1 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 40 | 75% | $257.58 | +27.8% |
| AMGN | Hold | 44 | 48% | $190.87 | -42.5% |
| GILD | Strong Buy | 39 | 79% | $362.68 | +176.2% |
| VRTX | Strong Buy | 39 | 79% | $438.34 | +2.0% |
| REGN | Strong Buy | 38 | 79% | $76.80 | -89.3% |
| ALNY | Strong Buy | 36 | 75% | $102.31 | -65.3% |
| RVMD | Strong Buy | 27 | 96% | $114.11 | -19.5% |
| INSM | Strong Buy | 28 | 96% | $143.40 | +41.5% |